vs

Side-by-side financial comparison of Federal Realty Investment Trust (FRT) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $336.0M, roughly 4.0× Federal Realty Investment Trust). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 7.3%, a 31.3% gap on every dollar of revenue. On growth, Federal Realty Investment Trust posted the faster year-over-year revenue change (8.7% vs 4.8%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 6.5%).

Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

FRT vs HAE — Head-to-Head

Bigger by revenue
HAE
HAE
4.0× larger
HAE
$1.3B
$336.0M
FRT
Growing faster (revenue YoY)
FRT
FRT
+3.9% gap
FRT
8.7%
4.8%
HAE
Higher net margin
FRT
FRT
31.3% more per $
FRT
38.6%
7.3%
HAE
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
6.5%
FRT

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
FRT
FRT
HAE
HAE
Revenue
$336.0M
$1.3B
Net Profit
$129.7M
$97.3M
Gross Margin
14.9%
Operating Margin
53.8%
83.4%
Net Margin
38.6%
7.3%
Revenue YoY
8.7%
4.8%
Net Profit YoY
103.5%
-42.0%
EPS (diluted)
$1.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRT
FRT
HAE
HAE
Q1 26
$336.0M
$1.3B
Q4 25
$336.0M
$339.0M
Q3 25
$322.3M
$327.3M
Q2 25
$311.5M
$321.4M
Q1 25
$309.2M
$330.6M
Q4 24
$311.4M
$348.5M
Q3 24
$303.6M
$345.5M
Q2 24
$296.1M
$336.2M
Net Profit
FRT
FRT
HAE
HAE
Q1 26
$129.7M
$97.3M
Q4 25
$129.7M
$44.7M
Q3 25
$61.6M
$38.7M
Q2 25
$155.9M
$34.0M
Q1 25
$63.8M
$58.0M
Q4 24
$65.5M
$37.5M
Q3 24
$61.0M
$33.8M
Q2 24
$112.0M
$38.4M
Gross Margin
FRT
FRT
HAE
HAE
Q1 26
14.9%
Q4 25
59.7%
Q3 25
59.5%
Q2 25
59.8%
Q1 25
58.4%
Q4 24
55.5%
Q3 24
54.2%
Q2 24
52.0%
Operating Margin
FRT
FRT
HAE
HAE
Q1 26
53.8%
83.4%
Q4 25
53.8%
19.9%
Q3 25
34.3%
17.9%
Q2 25
65.1%
16.8%
Q1 25
35.0%
21.6%
Q4 24
35.1%
16.9%
Q3 24
34.9%
15.0%
Q2 24
53.0%
11.8%
Net Margin
FRT
FRT
HAE
HAE
Q1 26
38.6%
7.3%
Q4 25
38.6%
13.2%
Q3 25
19.1%
11.8%
Q2 25
50.0%
10.6%
Q1 25
20.6%
17.5%
Q4 24
21.0%
10.8%
Q3 24
20.1%
9.8%
Q2 24
37.8%
11.4%
EPS (diluted)
FRT
FRT
HAE
HAE
Q1 26
$1.49
Q4 25
$1.49
$0.95
Q3 25
$0.69
$0.81
Q2 25
$1.78
$0.70
Q1 25
$0.72
$1.17
Q4 24
$0.74
$0.74
Q3 24
$0.70
$0.66
Q2 24
$1.32
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRT
FRT
HAE
HAE
Cash + ST InvestmentsLiquidity on hand
$107.4M
$245.4M
Total DebtLower is stronger
$5.0B
$1.2B
Stockholders' EquityBook value
$3.2B
$796.3M
Total Assets
$9.1B
$2.4B
Debt / EquityLower = less leverage
1.53×
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRT
FRT
HAE
HAE
Q1 26
$107.4M
$245.4M
Q4 25
$107.4M
$363.4M
Q3 25
$111.3M
$296.4M
Q2 25
$177.0M
$292.9M
Q1 25
$109.2M
$306.8M
Q4 24
$123.4M
$320.8M
Q3 24
$97.0M
$299.3M
Q2 24
$103.2M
$344.4M
Total Debt
FRT
FRT
HAE
HAE
Q1 26
$5.0B
$1.2B
Q4 25
$5.0B
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$4.5B
Q3 24
Q2 24
Stockholders' Equity
FRT
FRT
HAE
HAE
Q1 26
$3.2B
$796.3M
Q4 25
$3.2B
$911.5M
Q3 25
$3.2B
$849.2M
Q2 25
$3.2B
$882.3M
Q1 25
$3.2B
$820.8M
Q4 24
$3.2B
$906.9M
Q3 24
$3.1B
$878.9M
Q2 24
$3.0B
$905.4M
Total Assets
FRT
FRT
HAE
HAE
Q1 26
$9.1B
$2.4B
Q4 25
$9.1B
$2.5B
Q3 25
$8.9B
$2.4B
Q2 25
$8.6B
$2.5B
Q1 25
$8.6B
$2.5B
Q4 24
$8.5B
$2.5B
Q3 24
$8.5B
$2.5B
Q2 24
$8.4B
$2.5B
Debt / Equity
FRT
FRT
HAE
HAE
Q1 26
1.53×
1.53×
Q4 25
1.53×
1.34×
Q3 25
1.44×
Q2 25
1.39×
Q1 25
1.49×
Q4 24
1.42×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRT
FRT
HAE
HAE
Operating Cash FlowLast quarter
$293.2M
Free Cash FlowOCF − Capex
$209.9M
FCF MarginFCF / Revenue
15.7%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
3.01×
TTM Free Cash FlowTrailing 4 quarters
$417.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRT
FRT
HAE
HAE
Q1 26
$293.2M
Q4 25
$622.4M
$93.6M
Q3 25
$147.8M
$111.3M
Q2 25
$150.7M
$17.4M
Q1 25
$179.0M
$116.6M
Q4 24
$574.6M
$43.8M
Q3 24
$144.1M
$48.8M
Q2 24
$169.7M
$-27.4M
Free Cash Flow
FRT
FRT
HAE
HAE
Q1 26
$209.9M
Q4 25
$87.2M
Q3 25
$106.3M
Q2 25
$13.6M
Q1 25
$100.9M
Q4 24
$35.2M
Q3 24
$39.4M
Q2 24
$-33.1M
FCF Margin
FRT
FRT
HAE
HAE
Q1 26
15.7%
Q4 25
25.7%
Q3 25
32.5%
Q2 25
4.2%
Q1 25
30.5%
Q4 24
10.1%
Q3 24
11.4%
Q2 24
-9.8%
Capex Intensity
FRT
FRT
HAE
HAE
Q1 26
2.5%
Q4 25
1.9%
Q3 25
1.5%
Q2 25
1.2%
Q1 25
4.7%
Q4 24
2.5%
Q3 24
2.7%
Q2 24
1.7%
Cash Conversion
FRT
FRT
HAE
HAE
Q1 26
3.01×
Q4 25
4.80×
2.09×
Q3 25
2.40×
2.88×
Q2 25
0.97×
0.51×
Q1 25
2.81×
2.01×
Q4 24
8.77×
1.17×
Q3 24
2.36×
1.44×
Q2 24
1.52×
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons